June 2017 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2015/16 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2019
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand is listed
The decisions were as follows:
| Chemical name | Current price | New price | Hospital Supply Brand (Supplier) |
DV Limit | Listing date | Hospital Supply Status date | Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|
| Voriconazole* | $185.00 | $65.00 | Generic Partners (Generic Partners) |
1% | 1 December 2017 | 1 February 2018 | Vfend (Pfizer) |
2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
|
Aminophylline |
Inj 25 mg per ml, 10 ml ampoule; |
$118.25 |
$124.37 |
DBL Aminophylline |
1 September 2017 |
1 December 2017 |
|
Bendroflumethiazide [bendrofluazide]* |
Tab 2.5 mg, 500 tablets, bottle pack |
$5.48 |
$12.50 |
Arrow-Bendrofluazide (Actavis) |
1 January 2018 |
1 April 2018 |
|
Bendroflumethiazide [bendrofluazide]* |
Tab 5 mg, 500 tablets, bottle pack |
$8.95 |
$20.42 |
Arrow-Bendrofluazide (Actavis) |
1 January 2018 |
1 April 2018 |
|
Calcium carbonate* |
Tab 1.25 g (500 mg elemental), 250 tablets, bottle pack |
$5.38 |
$7.52 |
Arrow-Calcium |
1 January 2018 |
1 April 2018 |
|
Clotrimazole |
Crm 1%, 20 g OP tube |
$0.52 |
$0.70 |
Clomazol |
1 November 2017 |
1 February 2018 |
|
Desmopressin acetate |
Nasal spray 10 mcg per dose, 6 ml OP bottle |
$22.95 |
$23.95 |
Desmopressin-PH&T |
1 August 2017 |
1 November 2017 |
|
Diazepam* |
Tab 2 mg, 500 tablets, bottle pack |
$11.44 |
$15.05 |
Arrow-Diazepam |
1 January 2018 |
1 April 2018 |
|
Diazepam* |
Tab 5 mg, 500 tablets, bottle pack |
$13.71 |
$16.18 |
Arrow-Diazepam |
1 January 2018 |
1 April 2018 |
|
Emulsifying ointment |
Oint BP, 500 g tub |
$2.73 |
$3.59 |
AFT |
1 August 2017 |
1 November 2017 |
|
Ergometrine maleate |
Inj 500 mcg per ml, 1 ml ampoule; |
$94.70 |
$105.00 |
DBL Ergometrine |
1 September 2017 |
1 December 2017 |
|
Fentanyl |
Patch 12.5 mcg per hour, 5 patches |
$2.92 |
$2.95 |
Fentanyl Sandoz |
1 August 2017 |
1 November 2017 |
|
Fentanyl |
Patch 25 mcg per hour, 5 patches |
$3.66 |
$3.66 |
Fentanyl Sandoz |
1 August 2017 |
1 November 2017 |
|
Fentanyl |
Patch 50 mcg per hour, 5 patches |
$6.64 |
$6.65 |
Fentanyl Sandoz |
1 August 2017 |
1 November 2017 |
|
Fentanyl |
Patch 75 mcg per hour, 5 patches |
$9.18 |
$9.25 |
Fentanyl Sandoz |
1 August 2017 |
1 November 2017 |
|
Fentanyl |
Patch 100 mcg per hour, 5 patches |
$11.29 |
$11.40 |
Fentanyl Sandoz |
1 August 2017 |
1 November 2017 |
|
Glucose [Dextrose]* |
Inj 50%, 10 ml ampoule; |
$27.50 |
$29.50 |
Biomed |
1 August 2017 |
1 November 2017 |
|
Glucose [Dextrose]* |
Inj 50%, 90 ml bottle; |
$14.50 |
$14.50 |
Biomed |
1 August 2017 |
1 November 2017 |
|
Imatinib mesilate |
Cap 100 mg, 60 capsules, blister pack |
$298.90 |
$98.00 |
Imatinib-AFT |
1 August 2017 |
1 November 2017 |
|
Imatinib mesilate |
Cap 400 mg, 30 capsules, blister pack |
$597.80 |
$197.50 |
Imatinib-AFT |
1 August 2017 |
1 November 2017 |
|
Ipratropium bromide |
Aqueous nasal spray, 0.03%; 15 ml OP; |
$3.95 |
$4.61 |
Univent |
1 August 2017 |
1 November 2017 |
|
Isosorbide mononitrate |
Tab 20 mg, 100 tablets, blister pack |
$17.10 |
$18.80 |
ISMO 20 |
1 August 2017 |
1 November 2017 |
|
Ispaghula (psyllium) husk |
Powder for oral soln, 500 g OP; |
$5.51 |
$6.05 |
Konsyl-D |
1 August 2017 |
1 November 2017 |
|
Miconazole nitrate |
Crm 2%, 15 g OP; |
$0.55 |
$0.74 |
Multichem |
1 November 2017 |
1 February 2018 |
|
Nicotinic acid |
Tab 50 mg, 100 tablets, bottle pack |
$3.96 |
$4.12 |
Apo-Nicotinic acid |
1 August 2017 |
1 November 2017 |
|
Nicotinic acid |
Tab 500 mg, 100 tablets, bottle pack |
$17.37 |
$17.89 |
Apo-Nicotinic acid |
1 August 2017 |
1 November 2017 |
|
Octreotide |
Inj 50 mcg per ml, 1 ml vial, 5 vials |
$13.50 |
$30.64 |
DBL Octreotide |
1 September 2017 |
1 December 2017 |
|
Octreotide |
Inj 100 mcg per ml, 1 ml vial, 5 vials |
$22.40 |
$18.69 |
DBL Octreotide |
1 September 2017 |
1 December 2017 |
|
Octreotide |
Inj 500 mcg per ml, 1 ml vial, 5 vials |
$89.40 |
$72.50 |
DBL Octreotide |
1 September 2017 |
1 December 2017 |
|
Oestriol |
Crm 1 mg per g with applicator, 15 g OP tube |
$6.30 |
$6.62 |
Ovestin |
1 August 2017 |
1 November 2017 |
|
Oestriol |
Pessaries 500 mcg, 15 pessaries, blister pack |
$6.53 |
$6.86 |
Ovestin |
1 August 2017 |
1 November 2017 |
|
Paracetamol* |
Oral liq 120 mg per 5 ml, 1,000 ml bottle |
$4.15 |
$5.35 |
Paracare |
1 October 2017 |
1 January 2018 |
|
Pegylated interferon alpha-2a |
Inj 180 mcg prefilled syringe, 4 syringes |
$900.00 |
$500.00 |
Pegasys |
1 August 2017 |
1 November 2017 |
|
Permethrin* |
Crm 5%, 30 g OP tube |
$4.20 |
$4.95 |
Lyderm |
1 October 2017 |
1 January 2018 |
|
Permethrin |
Lotn 5%, 30 ml OP bottle |
$3.19 |
$3.69 |
A-Scabies |
1 August 2017 |
1 November 2017 |
|
Pyridoxine hydrochloride |
Tab 25 mg, 90 tablets, bottle pack |
$2.15 |
$2.70 |
Vitamin B6 25 |
1 November 2017 |
1 February 2018 |
|
Pyridoxine hydrochloride |
Tab 50 mg, 500 tablets, bottle pack |
$11.55 |
$13.63 |
Apo-Pyridoxine |
1 August 2017 |
1 November 2017 |
|
Ranitidine |
Oral liq 150 mg per 10 ml, 300 ml bottle |
$4.92 |
$5.14 |
Peptisoothe |
1 August 2017 |
1 November 2017 |
|
Ranitidine |
Tab 150 mg, 500 tablets, blister pack |
$10.30 |
$12.91 |
Ranitidine Relief |
1 August 2017 |
1 November 2017 |
|
Ranitidine |
Tab 300 mg, 500 tablets, blister pack |
$14.73 |
$18.21 |
Ranitidine Relief |
1 August 2017 |
1 November 2017 |
|
Pine tar with trolamine laurilsulfate and fluorescein |
Soln 2.3% with trolamine laurilsulfate and fluorescein sodium, 500 ml bottle |
$3.36 |
$3.86 |
Pinetarsol |
1 August 2017 |
1 November 2017 |
|
Trimethoprim with sulphamethoxazole [Co-trimoxazole] |
Oral liq 8 mg with sulphamethoxazole 40 mg per ml, 100 ml bottle |
$2.15 |
$2.97 |
Deprim |
1 August 2017 |
1 November 2017 |
*These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender. |
||||||
Tenders awarded to pharmaceuticals where at least one other brand is listed
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Bicalutamide | Tab 50 mg; 28 tablets, blister pack |
$4.90 | $3.80 | Binarex (Rex Medical) | 1 December 2017 | 1 February 2018 | 1 May 2018 | Bicalaccord (Actavis) |
| Ezetimibe* | Tab 10 mg, 30 tablets, blister pack | $3.35 | $2.00 | Ezetimibe Sandoz (Novartis) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Ezetimibe (Mylan) |
| Ibuprofen | Tab 200 mg, 1,000 tablets, blister pack | $9.45 | $11.71 | Relieve (Mylan) | 1 December 2017 | N/A | 1 May 2018 | Ibugesic (Rex Medical) |
| Omeprazole | Cap 10 mg, 90 capsules, bottle pack | $2.23 | $1.98 | Omeprazole Actavis 10 (Actavis) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Omezol Relief (Mylan) |
| Omeprazole | Cap 20 mg, 90 capsules, bottle pack | $2.91 | $1.96 | Omeprazole Actavis 20 (Actavis) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Omezol Relief (Mylan) |
| Omeprazole | Cap 40 mg, 90 capsules, bottle pack | $4.42 | $3.12 | Omeprazole Actavis 40 (Actavis) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Omezol Relief (Mylan) |
| Pravastatin | Tab 20 mg, 100 tablets, bottle pack | $3.45 per 30 tabs | $4.72 | Apo-Pravastatin (Apotex) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Cholvastin (Douglas) |
| Pravastatin | Tab 40 mg, 100 tablets, bottle pack | $6.36 per 30 tabs | $8.06 | Apo-Pravastatin (Apotex) | 1 January 2018 | 1 March 2018 | 1 June 2018 | Cholvastin (Douglas) |
| Prochlorperazine | Tab 5 mg, 250 tablets, blister pack | $9.75 per 500 tabs | $6.35 | Nausafix (Actavis) | 1 January 2018 | N/A | 1 June 2018 | Antinaus (Mylan) |
* The three months dispensed all-at-once (Stat dispensing) rule will be added to ezetimibe tablets from 1 June 2018. |
||||||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical Name |
Presentation; |
Current price |
New price |
Hospital Supply |
DV |
Listing date |
Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
|
Aminophylline |
Inj 25 mg per ml, 10 ml ampoule; |
$118.25 |
$124.37 |
DBL Aminophylline |
1% |
1 September 2017 |
1 November 2017 |
|
Bendroflumethiazide [bendrofluazide]* |
Tab 2.5 mg, 500 tablets, bottle pack |
$5.48 |
$12.50 |
Arrow-Bendrofluazide (Actavis) |
1% |
1 January 2018 |
1 March 2018 |
|
Bendroflumethiazide [bendrofluazide]* |
Tab 5 mg, 500 tablets, bottle pack |
$8.95 |
$20.42 |
Arrow-Bendrofluazide (Actavis) |
1% |
1 January 2018 |
1 March 2018 |
|
Calcium carbonate* |
Tab 1.25 g (500 mg elemental), 250 tablets, bottle pack |
$5.38 |
$7.52 |
Arrow-Calcium |
1% |
1 January 2018 |
1 March 2018 |
|
Clotrimazole |
Crm 1%, 20 g; |
$0.52 |
$0.70 |
Clomazol |
1% |
1 November 2017 |
1 January 2018 |
|
Desmopressin acetate |
Nasal spray 10 mcg per dose, 6 ml bottle |
$22.95 |
$23.95 |
Desmopressin-PH&T |
1% |
1 August 2017 |
1 October 2017 |
|
Diazepam* |
Tab 2 mg, 500 tablets, bottle pack |
$11.44 |
$15.05 |
Arrow-Diazepam |
1% |
1 January 2018 |
1 March 2018 |
|
Diazepam* |
Tab 5 mg, 500 tablets, bottle pack |
$13.71 |
$16.18 |
Arrow-Diazepam |
1% |
1 January 2018 |
1 March 2018 |
|
Emulsifying ointment |
Oint BP, 500 g; tub |
$2.73 |
$3.59 |
AFT |
1% |
1 August 2017 |
1 October 2017 |
|
Ergometrine maleate |
Inj 500 mcg per ml, 1 ml ampoule; 5 ampoules |
$94.70 |
$105.00 |
DBL Ergometrine |
1% |
1 September 2017 |
1 November 2017 |
|
Fentanyl |
Patch 12.5 mcg per hour, 5 patches |
$2.92 |
$2.95 |
Fentanyl Sandoz |
1% |
1 August 2017 |
1 October 2017 |
|
Fentanyl |
Patch 25 mcg per hour, 5 patches |
$3.66 |
$3.66 |
Fentanyl Sandoz |
1% |
1 August 2017 |
1 October 2017 |
|
Fentanyl |
Patch 50 mcg per hour, 5 patches |
$6.64 |
$6.65 |
Fentanyl Sandoz |
1% |
1 August 2017 |
1 October 2017 |
|
Fentanyl |
Patch 75 mcg per hour, 5 patches |
$9.18 |
$9.25 |
Fentanyl Sandoz |
1% |
1 August 2017 |
1 October 2017 |
|
Fentanyl |
Patch 100 mcg per hour, 5 patches |
$11.29 |
$11.40 |
Fentanyl Sandoz |
1% |
1 August 2017 |
1 October 2017 |
|
Glucose [Dextrose]* |
Inj 50%, 10 ml ampoule; |
$27.50 |
$29.50 |
Biomed |
1% |
1 August 2017 |
1 October 2017 |
|
Glucose [Dextrose]* |
Inj 50%, 90 ml bottle; |
$14.50 |
$14.50 |
Biomed |
1% |
1 August 2017 |
1 October 2017 |
|
Imatinib mesilate |
Cap 100 mg, 60 capsules, blister pack |
$298.90 |
$98.00 |
Imatinib-AFT |
1% |
1 August 2017 |
1 October 2017 |
|
Imatinib mesilate |
Cap 400 mg, 30 capsules, blister pack |
$597.80 |
$197.50 |
Imatinib-AFT |
1% |
1 August 2017 |
1 October 2017 |
|
Ipratropium bromide |
Aqueous nasal spray, 0.03%; |
$3.95 |
$4.61 |
Univent |
1% |
1 August 2017 |
1 October 2017 |
|
Isosorbide mononitrate |
Tab 20 mg, 100 tablets, blister pack |
$17.10 |
$18.80 |
ISMO 20 |
1% |
1 August 2017 |
1 October 2017 |
|
Ispaghula (psyllium) husk |
Powder for oral soln, 500 g tub |
$5.51 |
$6.05 |
Konsyl-D |
1% |
1 August 2017 |
1 October 2017 |
|
Miconazole nitrate |
Crm 2%, 15 g tube |
$0.55 |
$0.74 |
Multichem |
1% |
1 November 2017 |
1 January 2018 |
|
Nicotinic acid |
Tab 50 mg, 100 tablets, bottle pack |
$3.96 |
$4.12 |
Apo-Nicotinic acid |
1% |
1 August 2017 |
1 October 2017 |
|
Nicotinic acid |
Tab 500 mg, 100 tablets, bottle pack |
$17.37 |
$17.89 |
Apo-Nicotinic acid |
1% |
1 August 2017 |
1 October 2017 |
|
Octreotide |
Inj 50 mcg per ml, 1 ml vial, 5 vials |
$13.50 |
$30.64 |
DBL Octreotide |
1% |
1 September 2017 |
1 November 2017 |
|
Octreotide |
Inj 100 mcg per ml, 1 ml vial, 5 vials |
$22.40 |
$18.69 |
DBL Octreotide |
1% |
1 September 2017 |
1 November 2017 |
|
Octreotide |
Inj 500 mcg per ml, 1 ml vial, 5 vials |
$89.40 |
$72.50 |
DBL Octreotide |
1% |
1 September 2017 |
1 November 2017 |
|
Paclitaxel** |
Inj 6 mg per ml, 5 ml vial, 5 vials |
$45.00 |
$47.30 |
Paclitaxel Ebewe |
1% |
1 August 2017 |
1 October 2017 |
|
Paclitaxel** |
Inj 6 mg per ml, 16.7 ml vial, 1 vial |
$19.02 |
$20.00 |
Paclitaxel Ebewe |
1% |
1 August 2017 |
1 October 2017 |
|
Paclitaxel** |
Inj 6 mg per ml, 50 ml vial, 1 vial |
$36.53 |
$35.35 |
Paclitaxel Ebewe |
1% |
1 August 2017 |
1 October 2017 |
|
Paracetamol* |
Oral liq 120 mg per 5 ml, 1,000 ml bottle |
$4.15 |
$5.35 |
Paracare |
1% |
1 October 2017 |
1 December 2017 |
|
Pegylated interferon alpha-2a |
Inj 180 mcg prefilled syringe, 4 syringes |
$900.00 |
$500.00 |
Pegasys |
1% |
1 August 2017 |
1 October 2017 |
|
Permethrin* |
Crm 5%, 30 g tube |
$4.20 |
$4.95 |
Lyderm |
1% |
1 October 2017 |
1 December 2017 |
|
Permethrin |
Lotn 5%, 30 ml bottle |
$3.19 |
$3.69 |
A-Scabies |
1% |
1 August 2017 |
1 October 2017 |
|
Pyridoxine hydrochloride |
Tab 25 mg, 90 tablets, bottle pack |
$2.15 |
$2.70 |
Vitamin B6 25 |
1% |
1 November 2017 |
1 January 2018 |
|
Pyridoxine hydrochloride |
Tab 50 mg, 500 tablets, bottle pack |
$11.55 |
$13.63 |
Apo-Pyridoxine |
1% |
1 August 2017 |
1 October 2017 |
|
Ranitidine |
Oral liq 150 mg per 10 ml, 300 ml bottle |
$4.92 |
$5.14 |
Peptisoothe |
1% |
1 August 2017 |
1 October 2017 |
|
Ranitidine |
Tab 150 mg, 500 tablets, blister pack |
$10.30 |
$12.91 |
Ranitidine Relief |
1% |
1 August 2017 |
1 October 2017 |
|
Ranitidine |
Tab 300 mg, 500 tablets, blister pack |
$14.73 |
$18.21 |
Ranitidine Relief |
1% |
1 August 2017 |
1 October 2017 |
|
Trimethoprim with sulphamethoxazole [Co-trimoxazole] |
Oral liq 8 mg with sulphamethoxazole 40 mg per ml, 100 ml bottle |
$2.15 |
$2.97 |
Deprim |
1% |
1 August 2017 |
1 October 2017 |
*These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedules 6, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender.**Prices of paclitaxel will change in section B of the pharmaceutical schedule from 1 August 2017 including a change for Inj 1 mg for ECP from $0.17 to $0.19. |
|||||||
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current price | New price | Hospital Supply Brand (Supplier) | DV Limit | Listing date | Hospital Supply Status date | Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
| Bicalutamide | Tab 50 mg; 28 tablets, blister pack |
$4.90 | $3.80 | Binarex (Rex Medical) |
1% | 1 December 2017 | 1 February 2018 | Bicalaccord (Actavis) |
| Ezetimibe | Tab 10 mg, 30 tablets, blister pack | $3.35 | $2.00 | Ezetimibe Sandoz (Novartis) |
1% | 1 January 2018 | 1 March 2018 | Ezetimibe (Mylan) |
| Metronidazole | Inj 5 mg per ml, 100 ml bag, 10 bags | $6.94 per 5 bags | $12.43 | DBL Metronidazole Intravenous Infusion (Pfizer) |
1% | 1 February 2018 | 1 April 2018 | AFT (AFT) |
| Morphine sulphate* | Inj 1 mg per ml, 10 ml syringe, 5 syringes | $45.00 per 10 syringes | $24.00 | Biomed (Biomed) |
1% | 1 August 2017 | 1 October 2017 | Biomed(Biomed)10 syringe pack |
| Morphine sulphate* | Inj 1 mg per ml, 50 ml syringe, 5 syringes | $87.50 per 10 syringes | $50.75 | Biomed (Biomed) |
1% | 1 August 2017 | 1 October 2017 | Biomed(Biomed)10 syringe pack |
| Morphine sulphate* | Inj 1 mg per ml, 100 ml bag, 5 bags | $185.00 per 10 bags | $97.25 | Biomed (Biomed)) |
1% | 1 August 2017 | 1 October 2017 | Biomed(Biomed)10 bag pack |
| Omeprazole | Cap 10 mg, 90 capsules, bottle pack | $2.23 | $1.98 | Omeprazole Actavis 10 (Actavis) |
1% | 1 January 2018 | 1 March 2018 | Omezol Relief (Mylan) |
| Omeprazole | Cap 20 mg, 90 capsules, bottle pack | $2.91 | $1.96 | Omeprazole Actavis 20 (Actavis) |
1% | 1 January 2018 | 1 March 2018 | Omezol Relief (Mylan) |
| Omeprazole | Cap 40 mg, 90 capsules, bottle pack | $4.42 | $3.12 | Omeprazole Actavis 40 (Actavis) |
1% | 1 January 2018 | 1 March 2018 | Omezol Relief (Mylan) |
| Pine tar with trolamine laurilsulfate and fluorescein | Soln 2.3% with trolamine laurilsulfate and fluorescein sodium, 500 ml bottle | $3.36 | $3.86 | Pinetarsol (Douglas) |
1% | 1 August 2017 | 1 October 2017 | Pinetarsol(Douglas)1,000 ml bottle |
| Pravastatin | Tab 20 mg, 100 tablets, bottle pack | $3.45 per 30 tabs | $4.72 | Apo-Pravastatin (Apotex) |
1% | 1 January 2018 | 1 March 2018 | Cholvastin (Douglas) |
| Pravastatin | Tab 40 mg, 100 tablets, bottle pack | $6.36 per 30 tabs | $8.06 | Apo-Pravastatin (Apotex) |
1% | 1 January 2018 | 1 March 2018 | Cholvastin (Douglas) |
| Prochlorperazine | Tab 5 mg, 250 tablets, blister pack | $9.75 per 500 tab | $6.35 | Nausafix (Actavis) |
1% | 1 January 2018 | 1 March 2018 | Antinaus (Mylan) |
*These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedules 6, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender. |
||||||||
Tenders awarded to pharmaceuticals where no brand is listed
The decisions were as follows:
|
Chemical name |
Presentation; |
Pack Price |
Hospital Supply |
DV Limit |
Listing date |
Hospital Supply Status date |
|---|---|---|---|---|---|---|
|
Oestriol |
Crm 1 mg per g with applicator, 15 g tube |
$6.62 |
Oestriol |
1% |
1 August 2017 |
1 October 2017 |
|
Oestriol |
Pessaries 500 mcg, 15 pessaries, blister pack |
$6.86 |
Oestriol |
1% |
1 August 2017 |
1 October 2017 |
|
Ibuprofen |
Tab 200 mg, 1,000 tablets, blister pack |
$11.71 |
Relieve |
1% |
1 December 2017 |
1 February 2018 |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2014/15 Invitation to Tender dated 6 November 2014, the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016:
2014/15 Invitation to Tender
| Chemical Name | Line Item |
|---|---|
| Atropine sulfate | Inj 600 mcg, 1 ml |
| Celiprolol | Tab 200 mg |
| Chloramphenicol | Inj 1 g |
| Clonidine | Inj 150 mcg per ml, 1 ml |
| Lidocaine [lignocaine] hydrochloride with adrenaline | Inj 2% with adrenaline 1:80,000, 2.2 ml dental cartridge |
| Metformin | Tab immediate-release 1 g |
| Naloxone hydrochloride | Inj 400 mcg per ml, 1 ml |
2015/16 Invitation to Tender
| Chemical Name | Line Item |
|---|---|
| Ambrisentan | Tab 5 mg |
| Ambrisentan | Tab 10 mg |
| Azacitidine | Inj 100 mcg |
| Bacillus Calmette-Guerin (BCG) vaccine | Inj containing equal to or greater than 500 million CFU |
| Colchicine | Tab 500 mcg |
| Eptifibatide | Inj 0.75 mg per ml, 100 ml |
| Eptifibatide | Inj 2 mg per ml, 10 ml |
| Ibuprofen | Oral liq 20 mg per ml |
2016/17 Invitation to Tender
| Chemical Name | Line Item |
|---|---|
| Paracetamol | Inj 10 mg per ml, 50 ml |
For products included in the 2014/15, 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.